Issue
Title
Authors
High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience
Mochkin N.E., Sarzhevskiy V.O., Dubinina J.N., Smirnova E.G., Fedorenko D.A., Bannikova A.E., Kolesnikova D.S., Bogatyrev V.S., Samoylova A.A., Faddeev N.M., Melnichenko V.Y.
Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience
Kolyadina I.V., Ganshina I.P., Kuzmicheva S.V., Tekeeva A.I., Kolokolov J.D., Volkonskii M.V., Poddubnaya I.V.
Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial
Levashov A.S., Zagidullina S.R., Stroganova A.M., Khochenkov D.A., Ryzhova M.V., Gorelyshev S.K., Kadirov S.U., Babelyan S.S., Grigorenko V.A., Sidel’nikov D.A., Subbotina N.N., Daylidite V.V., Mentkevich G.L.
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
Kolyadina I.V., Poddubnaya I.V.
Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy
Artamonova E.V.
Primenenie lenograstima (granotsit) v onkologii
Minenko S.V.
The role of cytoreduction surgery in advanced ovarian cancer (review)
Tandelov R.K., Sel'chuk V.Y., Morkhov K.Y., Nechushkina V.M., Kuznetsov V.V.
Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO)
Zhukova L.G.
Dopolnitel'nye kliniko-laboratornye faktory prognoza pri diffuznoy krupnokletochnoy V-kletochnoy limfome
Babicheva L.G., Poddubnaya I.V.
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A.
Opyt primeneniya preparata Eloksatin pri kolorektal'nom rake
Voznyy E.K., Popov A.Y., Astrakhankina T.A., Grishunenkova E.P., Polyanskaya E.V.
Otsenka effektivnostii bezopasnosti fotemustinav monorezhime i v kombinatsii s proizvodnymi platiny(karboplatinom ili tsisplatinom) pri lechenii disseminirovannoy melanomy
Konstantinova M.M., Savkova R.F., Demidov L.V., Gorbunova V.A., Kharkevich G.Y., Antimonik N.Y., Merkulov V.N., Simanovich E.E., Ral'chenko K.V., Sbrodov O.V.
Rol' epoetina beta (RekormonR) v terapii anemii u patsientov s solidnymi opukholyami
Kazantseva M.V., Davidenko I.S.
Diagnosis and treatment of malignant trophoblastic tumors: errors, dangers, complications (review of the literature)
Gasanbekova Z.A., Aliev S.A., Meshcheryakova L.A., Kozachenko V.P., Kuznetsov V.V.
Gormonal'naya terapiya raka predstatel'noy zhelezy. Otsenka effektivnosti neoad\"yuvantnoy terapii bikalutamidom i gozerelinom v techenie 3 i 6 mesyatsev pered radikal'noy prostatektomiey
Rasner P.I., Pushkar' D.Y., Govorov A.V.
Limfoma iz kletok mantiynoy zony: klinicheskie osobennosti i vozmozhnosti terapii
Lorie Y.Y.
The role of cytokines in the chemotherapy of malignant tumors:the practice of cytokines Refnot® and Ingaron® administration in advanced cancer with multiple metastases
Bryuzgin V.V., Platinskij L.N.
ANAPLASTIChESKAYa KRUPNOKLETOChNAYa LIMFOMA VZROSLYKh:VLIYaNIE PROGNOSTIChESKIKh FAKTOROV NA TERAPIYu
Semenova A.A., Sorokin E.N., Poddubnaya I.V., Probatova N.A., Timofeeva O.L.
Rol' pemetrekseda (Alimta) v lechenii rasprostranennogo neploskokletochnogonemelkokletochnogo raka legkogo
Poddubnaya I.V.
Opyt primeneniya Taksotera v kombinatsii s doksorubitsinom v kachestve khimioterapii 1-y linii u bol'nykh metastaticheskim rakom molochnoy zhelezy
Samoylenko V.M., Gorbunova V.A., Koshelev M.N., Yurashko K.V.
Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
Artamonova E.V.
Tsetuksimab pri lechenii metastaticheskogo kolorektal'nogo raka
Sekacheva M.I., Skipenko O.G.
Otkrytaya mnogotsentrovaya programma po otsenke effektivnosti i bezopasnosti kombinirovannoy terapii myustoforanom, tsisplatinom, tamoksifenom patsientov s disseminirovannoy zlokachestvennoy melanomoy
Konstantinova M.M., Gershanovich M.L., Akimov M.A., Nosov D.A., Bogdanova N.V.
Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives
Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S., Kaprin A.D.
Primenenie tsetuksimaba v lechenii ploskokletochnogo raka golovy i shei
Romanov I.S., Kupchan D.Z.
Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer
Musaeva Z.R., Chekalova M.A., Mesheryakov A.A.
Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom
Zhukova L.G., Abramov M.E., Vakhabova Y.V., Lud A.N., Obukhov A.A., Lichinitser M.R.
Limfoma Khodzhkina: prognosticheskie priznaki segodnya
Demina E.A.
Experience in prevention of neutropenia in patients with disseminated soft tissue sarcomas receiving polychemotherapy
Vladimirova L.Y., Mitashok I.S., Snezhko T.A., Samaneva N.Y., Storozhakova A.E., Kornilova I.S.
Znachenie klinicheskikh i molekulyarno-geneticheskikh prediktorov otveta na terapiyu ingibitorami tirozinkinazy v vybore lechebnoy taktiki pri nemelkokletochnom rake legkogo
Smolin A.V., Konev A.V., Solovey T.G., Nikolaeva S.N., Shamanskaya Y.E.
Sovremennye vozmozhnosti lekarstvennoy terapii operabel'nogo raka molochnoy zhelezy (po materialam St. Gallen, 2005)
Letyagin V.P., Vysotskaya I.V.
High-dose chemotherapy with hematopoietic stem cell rescuein children older than 3 year with medulloblastoma: results of single institution trial
Babelyan S.S., Subbotina N.N., Dolgopolov I.S., Gorelyshev S.K., Mentkevich G.L., Byarshinov V.K., Pimenov R.I.
ASCO Innovatsionnye metody bor'by s onkologicheskimi zabolevaniyam
The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
Gordeeva O.O., Kolyadina I.V., Zhukova L.G., Gan'shina I.P., Komov D.V., Meshcheriakov A.A.
Klinicheskiy sluchay effektivnogo lecheniya lapatinibom (Tayverb)i kapetsitabinom (Kseloda) bol'noy disseminirovannym rakom molochnoy zhelezy s giperekspressiey ErbB2 (Her-2/neu) s metastaticheskim porazheniem veshchestva i obolochek golovnogo mozga
Naskhletashvili D.R., Chmutin G.E.
Klinicheskiy opyt primeneniya zomety u bol'nykh mnozhestvennoy mielomoy (rezul'taty Rossiyskogo mnogotsentrovogo issledovaniya)
Votyakova O.M., Khoroshko N.D., Zhuravlev V.S., Shamray V.S., Korobkin V.A., Shelekhova N.M.
Liposarcomas: morphological subtypes, prognostic factors and therapeutic options
Fedenko A.A.
Natulan pri lechenii limfomy Khodzhkina: ot MORR do VEASORR
Demina E.A.
Primenenie eritropoetina posle vysokodoznoy khimioterapii s transplantatsiey autologichnykh gemopoeticheskikh kletok
Ptushkin V.V., Zhukov N.V., Minenko S.V.
The role of angiogenesis blockers in the treatment of metastatic ovarian cancer
Oganian M.R., Kazantseva M.V., Davidenko I.S., Porhanova N.V.
Predvaritel'nye rezul'taty induktsionnoy khimioterapii s paklitakselom pri mestnorasprostranennom rake sheyki matki
Morkhov K.Y., Kuznetsov V.V., Lebedev A.I., Nechushkina V.M., Zakharova T.I., Tyulyandin S.A.
Modern ultrasound diagnostics for locally advanced cervical cancer
Ovodenko D.L., Khabas G.N., Makarova A.S., Pirogova M.S., Seregin A.A., Golitsyna Y.S., Ashrafyan L.A.
Rol' rituksimaba v lechenii nekhodzhkinskikh limfom(referativnyy obzor randomizirovannykh klinicheskikh issledovaniy)
Mikhaylova N.B.
Vysokodoznaya khimioterapiya i autotransplantatsiya pri mnozhestvennoy mielome
Mendeleeva L.P., Savchenko V.G., Tyurina N.G., Varlamova E.Y., Momotyuk K.S., Lyubimova L.S., Gribanova E.O., Ustinova E.N., Pokrovskaya O.S., Mitish N.E., Zherebtsova V.A., Kaplanskaya I.B., Vorob'ev I.A., Gretsov E.M., Kalinin N.N.
Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study
Ignatova E.O., Burdaeva O.N., Kopp M.V., Kotiv B.N., Udovitsa D.P., Stroiakovskii D.L., Alekseev S.M., Sheveleva L.P., Khorinko A.V., Shapovalova I.S., Moiseenko V.M., Ivanov R.A.
Sluchay uspeshnoy terapii nilotinibom (Tasignoy) patsientki s Ph-pozitivnymkhronicheskim mieloleykozom v khronicheskoy faze s rezistentnost'yu k interferonui Gliveku
Afanas'eva N.A., Gusarova G.A.
Sravnitel'naya kharakteristika taksanosoderzhashchikh i platinovykh skhem polikhimioterapii v pervoy linii lecheniya raka yaichnikov IV stadii (opyt GVKB im. N.N.Burdenko)
Mel'ko A.I., Ushakov I.I., Kira E.F., Ermolinskiy I.I.
New chemotherapy options for triple-negative breast cancer (review of literature)
Sekundova M.A., Zdvizhkov A.M., Borisov V.I.
Rezul'taty lecheniya Myustoforanom rasprostranennoy i metastaticheskoy form melanomy
Radyukova I.M., Kosenok V.K., Tarasevich A.D., Merkulov V.N., Kurakin V.I., Trenina N.A.
Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia
Gorbunova V.A., Kolyadina I.V., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Filonenko D.V., Zhilyaeva L.A., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Suslova I.R., Romanchuk O.V., Kozlov D.V., Rzaev A.S., Marfutov V.V., Andreiashkina I.I., Vladimirova L.I., Mitashok I.S., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Morozov D.A., Prokof'eva E.P., Kramskaia L.V., Karandeeva T.V., Evstigneeva I.V., Ovchinnikova E.G., Klement'eva T.P., Khrupalo O.V., Tiuvinova E.V., Sherstnev V.M., Chernov I.S., Kolokolov D.D., Gaisina E.A., Levchenko N.V., Chubenko V.A., Povyshev A.I., Iudina I.V., Vorotilina L.V., Andreeva T.V., Tumanian G.S., Koziakov A.E., Gil'mutdinova L.A., Osipov M.A., Shatokhina A.S., Vazhenina A.A., Chichkanova A.S., Vladimirov V.I., Ivanov A.N., Belokhvostova A.S., Cherniakova E.M., Tul'china E.A., Maklashova S.A., Shkodenko O.N., Kostalanova I.V., Tarasova A.V., Kuz'mina E.S.
Taktika vedeniya bol'nogo metastaticheskim kolorektal'nym rakom s izolirovannymi metastazami v pechen'
Tryakin A.A.
Opyt primeneniya vysokodoznoy khimioterapii pri retsidiviruyushchem techenii i refrakternykh formakh limfomy Khodzhkina (retrospektivnyy analiz dannykh chetyrekh transplantatsionnykh tsentrov Respubliki Belarus', Rossiyskoy Federatsii i Ukrainy)
Zhukov N.V., Uss A.L., Afanas'ev B.V., Karamanesht E.E., Ptushkin V.V.
Systemic drug therapy of metastatic pancreatic cancer
Pokataev I.A., Tyulyandin S.A.
Pervyy opyt primeneniya alemtuzumaba u bol'nykh khronicheskim limfoleykozom,refrakternykh k fludarabinsoderzhashchim programmam khimioterapii
Zagoskina T.P., Malykh O.V., Khorobrykh M.N., Dem'yanova V.I., Isaeva N.V., Grishina I.V.
Mezotelioma plevry: sovremennaya taktika lecheniya
Bychkov M.B., Bol'shakova S.A., Bychkov Y.M.
Opyt primeneniya Votrienta v kombinirovannom lechenii redkikh mestno-rasprostranennykh sarkom myagkikh tkaney vysokoy stepeni zlokachestvennosti
Zubarev A.L., Kuril'chik A.A., Starodubtsev A.L., Ivanov V.E.
Ad\"yuvantnoe lechenie raka tolstoy kishki
Artamonova E.V., Podregul'skiy K.E.
The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience
Kolyadina I.V., Bulavina I.S., Petkau V.V., Strakhova N.V., Gorbunova V.A., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Gan'shina I.P., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Khokhlova S.V., Filonenko D.V., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Vladimirova L.I., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Orlov A.E., Kostalanova I.V., Levchenko N.V., Osipov M.A., Karandeeva T.V., Evstigneeva I.V., Chernov I.S., Kolokolov D.D., Povyshev A.I., Shatokhina A.S., Cherniakova E.M., Shkodenko O.N., Kuz'mina E.S.
Neksavar® (sorafenib)v lechenii rasprostranennogo pochechno-kletochnogo raka
Podregul'skiy K.E.
Vysokodoznaya khimioterapiya s transplantatsiey autologichnykh kletok-predshestvennikov gemopoeza i primeneniem rituksimaba (mabtera) pri nekhodzhkinskikh limfomakh (opyt RONTs im. N.N.Blokhina RAMN)
Ptushkin V.V., Zhukov N.V., Minenko S.V., Mkheidze D.M., Grivtsova L.Y., Popov A.Y., Grishunenkova E.P., Chimishkyan K.L.
Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review)
Fedyanin M.I.
Ispol'zovanie generikov v onkologii: est' li problemy?
Zyryanov S.K., Belousov Y.B.
Vozmozhnosti lekarstvennoy terapii raka sheyki matki
Kharitonova T.V.
Role of vemurafenib in the treatment of disseminated skin melanoma
Demidov L.V., Utyashev I.A., Kharkevich G.Y.
Melkokletochnyy rak legkogo: chto izmenilos' za poslednie 30 let?
Bychkov M.B.
A method of laparoscopic installation of port systems for intra-abdominal chemotherapy in patients with advanced ovarian cancer
Lozovaya V.V., Cherkes L.V., Malikhova O.A., Poddubny B.K.
Kombinirovannoe lechenie metastazov kolorektal'nogo raka v pechen' s primeneniem regionarnoy khimioterapii
Kotiv B.N., Alent'ev S.A., Dzidzava I.I.
Vybor taktiki i rezul'taty lecheniya bol'nykh estezioneyroblastomoy
Mudunov A.M.
The illustration of the successful mobilization of hematopoietic stem cells using plerixafor and pegfilgrastim in the patient with non-hodgkin's lymphoma
Motalkina M.S., Kulyova S.A., Alexeev S.M., Zuzgin I.S., Filatova L.V., Zhabina A.S., Zverkova A.A., Ishmatova I.V., Rjazankina A.A., Artemyeva A.S., Semiglazova T.Y.
Tsetuksimab v lechenii ryada solidnykh opukholey: dostizheniya i perspektivy
Besova N.S., Khokhlova S.V., Romanov I.S., Gorbunova V.A., Matyakin E.G.
Farmorubitsin v klinicheskoy praktike
Gorbunova V.A.
Pathogenesis and correction of anemic syndrome in lymphoproliferative disorders patients
Romanenko N.A.
Prognosticheskie faktory effektivnosti lecheniya retsidiva raka yaichnikov IV stadii
Mel'ko A.I., Ushakov I.I., Kira E.F., Shamkina V.O., Gaytukieva R.A.
Sravnitel'noe issledovanie opredeleniya HER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
Rak cherveobraznogo otrostka (osobennosti klinicheskogo techeniya, diagnostiki i lecheniya)
Komov D.V., Kolesova O.V., Ivanova E.A.
Modern possibilities of targeted therapy in metastatic colorectal cancer
Gorbunova V.A.
Samoe masshtabnoe sravnitel'noe issledovanie III fazy iz vsekh ranee opublikovannykh pokazalo, chto IRESSATM (gefitinib) tak zhe effektivna, kak i dotsetaksel u patsientov s rasprostranennym nemelkokletochnym rakom legkogo posle neudachi predshestvuyushchey terapii
Astrotsitomy nizkoy stepeni zlokachestvennosti polushariy bol'shogo mozga
Aleshin V.A., Karakhan V.B.
Tartseva (erlotinib) v terapii rasprostranennoy adenokartsinomy legkogo pri nalichii mutatsii retseptora epidermal'nogo faktora rosta
Orlov S.V., Dvorakovskaya I.V., Mosin I.V., Stel'makh L.V., Gorokhov A.A., Martynenko O.N., Poltoratskiy A.N.
Znachenie luchevoy terapii v lechenii generalizovannykh nekhodzhkinskikh limfom (IV stadiya)
Kharchenko V.P., Pan'shin G.A., Sotnikov V.M., Datsenko P.V., Smol'tsova N.N., Nikolaeva E.V.
Pre-operative chemoradiation therapy in complex treatment of patients with locally advanced tumors of the thoracic esophagus
Shogenov M.S., Davydov M.M., Allakhverdiyev A.K., Chekini A.K., Filatov A.A., Akhmedov P.I., Serebryanskaya M.V., Korolyeva A.A., Dadyev I.A., Chichikov E.I., Grigorenko V.A., Kozlov N.A., Nazliyev P.B., Malikhova O.A., Tryakin A.A.
Rol' i mesto tsetuksimaba v 1-y linii terapii metastaticheskogo kolorektal'nogo raka
Kopp M.V., Koroleva I.A.
Sovremennye vozmozhnosti lecheniya kolorektal'nogo raka
Barsukov Y.A., Knysh V.I.
Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy
Krivorotko P.V., Burdaeva O.N., Nechaeva M.N., Frolova M.A., Kopp M.V., Abrosimova A.A., Ivanov R.A.
Primenenie kombinatsii T-VER u bol'nykhneseminomnymi germinogennymi opukholyami s plokhim prognozom: predvaritel'nye rezul'taty II fazy issledovaniya
Tryakin A.A., Tyulyandin S.A., Fedyanin M.Y., Sergeev Y.S., Faynshteyn I.A., Polotskiy B.E., Figurin K.M., Zakharova T.I., Garin A.M.
Sovremennye standarty lecheniya raka yaichnikov
Kharitonova T.V.
1 - 86 of 86 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies